DIHYDROROBINETIN

ID: ALA1163000

Max Phase: Preclinical

Molecular Formula: C15H12O7

Molecular Weight: 304.25

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (2): 3,7,3',4',5'-Pentahydroxyflavanone | Dihydrorobinetin
Synonyms from Alternative Forms(2):

    Canonical SMILES:  O=C1c2ccc(O)cc2O[C@@H](c2cc(O)c(O)c(O)c2)[C@@H]1O

    Standard InChI:  InChI=1S/C15H12O7/c16-7-1-2-8-11(5-7)22-15(14(21)12(8)19)6-3-9(17)13(20)10(18)4-6/h1-5,14-18,20-21H/t14-,15+/m1/s1

    Standard InChI Key:  VSJCDPYIMBSOKN-CABCVRRESA-N

    Associated Targets(Human)

    Monocyte 474 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    HEK293 82097 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Acetylcholinesterase 12221 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cholinesterase 8742 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 304.25Molecular Weight (Monoisotopic): 304.0583AlogP: 1.19#Rotatable Bonds: 1
    Polar Surface Area: 127.45Molecular Species: NEUTRALHBA: 7HBD: 5
    #RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 7.66CX Basic pKa: CX LogP: 1.17CX LogD: 0.97
    Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.50Np Likeness Score: 2.07

    References

    1. Lale A, Herbert JM, Augereau JM, Billon M, Leconte M, Gleye J..  (1996)  Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.,  59  (3): [PMID:8882428] [10.1021/np960057s]
    2. Lee S, Woo Y, Shin SY, Lee YH, Lim Y..  (2009)  Relationships between the structures of flavanone derivatives and their effects in enhancing early growth response-1 gene expression.,  19  (8): [PMID:19307119] [10.1016/j.bmcl.2009.03.017]
    3. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P..  (2012)  Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.,  20  (22): [PMID:23062825] [10.1016/j.bmc.2012.09.040]

    Source